Evidence map›Paper›PMID 25573176›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2015

Transcriptional corepressor MTG16 regulates small intestinal crypt proliferation and crypt regeneration after radiation-induced injury.

Shenika V Poindexter, Vishruth K Reddy, Mukul K Mittal, Amanda M Williams, M Kay Washington, Elizabeth Harris, Amanda Mah, Scott W Hiebert, Kshipra Singh, Rupesh Chaturvedi and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Use of organoids to study regenerative responses to intestinal damage.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Transcriptional Regulation by ATOH1 and its Target SPDEF in the Intestine.Cellular and molecular gastroenterology and hepatology · 2017
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Shenika V PoindexterDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Vishruth K ReddyDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, Tennessee.
Mukul K MittalDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee;
Amanda M WilliamsDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
M Kay WashingtonDepartment of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Elizabeth HarrisDepartment of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Amanda MahDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina;
Scott W HiebertDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Kshipra SinghDepartment of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee;
Rupesh ChaturvediDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
Keith T WilsonDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and.
P Kay LundDepartment of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina;
Christopher S WilliamsDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Medicine, Division of Gastroenterology, Vanderbilt University School of Medicine, Nashville, Tennessee; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee; and christopher.s.williams@vanderbilt.edu.
Vanderbilt University Medical Center · USVanderbilt University · USUniversity of North Carolina at Chapel Hill · USVA Tennessee Valley Healthcare System · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
INTESTINAL ADAPTATION-ROLE OF HORMONES &GROWTH FACTORSR01DK040247 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DING, SHENGLI · 1989 to 2014
$4.5M
Immunomodulatory effects of arginine supplementation in colitis and colon cancerR01AT004821 · NCCIH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 2008 to 2017
$4.0M
HPYLORI INDUCED DNA DAMAGE AND IMMUNE DYSREGULATIONR01DK053620 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1997 to 2014
$3.4M
Targeted chemoprevention of gastric carcinogenesis in high risk populationsR01CA190612 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MORGAN, DOUGLAS, WILSON, KEITH T. · 2014 to 2018
$3.0M
Regulation of transcription and tumor suppression by MTG family membersR01CA178030 · NCI · VANDERBILT UNIVERSITY · PI HIEBERT, SCOTT W · 2014 to 2018
$1.8M
Selenium in gastrointestinal inflammatory diseasesR01DK099204 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILLIAMS, CHRISTOPHER S. · 2014 to 2018
$1.8M
BLRD VA I01 BX001426BLRD VA I01 BX001453NCATS NIH HHS UL1TR000445NCCIH NIH HHS R01 AT004821NCI NIH HHS P30-CA-068485NCI NIH HHS P50 CA095103NCI NIH HHS P50-CA-095103NCI NIH HHS R01 CA178030NCI NIH HHS R01 CA190612NIDDK NIH HHS 1F30-DK-103498NIDDK NIH HHS F30 DK103498NIDDK NIH HHS K08-DK-080221NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30-DK-058404NIDDK NIH HHS R01-DK-040247NIDDK NIH HHS R01 DK053620NIDDK NIH HHS R01 DK099204NIDDK NIH HHS R01-DK-099204NIGMS NIH HHS R25 GM062459NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32-GM-07347
6 · The paper itself

Abstract

Myeloid translocation genes (MTGs) are transcriptional corepressors implicated in development, malignancy, differentiation, and stem cell function. While MTG16 loss renders mice sensitive to chemical colitis, the role of MTG16 in the small intestine is unknown. Histological examination revealed that Mtg16(-/-) mice have increased enterocyte proliferation and goblet cell deficiency. After exposure to radiation, Mtg16(-/-) mice exhibited increased crypt viability and decreased apoptosis compared with wild-type (WT) mice. Flow cytometric and immunofluorescence analysis of intestinal epithelial cells for phospho-histone H2A.X also indicated decreased DNA damage and apoptosis in Mtg16(-/-) intestines. To determine if Mtg16 deletion affected epithelial cells in a cell-autonomous fashion, intestinal crypts were isolated from Mtg16(-/-) mice. Mtg16(-/-) and WT intestinal crypts showed similar enterosphere forming efficiencies when cultured in the presence of EGF, Noggin, and R-spondin. However, when Mtg16(-/-) crypts were cultured in the presence of Wnt3a, they demonstrated higher enterosphere forming efficiencies and delayed progression to mature enteroids. Mtg16(-/-) intestinal crypts isolated from irradiated mice exhibited increased survival compared with WT intestinal crypts. Interestingly, Mtg16 expression was reduced in a stem cell-enriched population at the time of crypt regeneration. This is consistent with MTG16 negatively regulating regeneration in vivo. Taken together, our data demonstrate that MTG16 loss promotes radioresistance and impacts intestinal stem cell function, possibly due to shifting cellular response away from DNA damage-induced apoptosis and towards DNA repair after injury.

Indexed as

Cell ProliferationGamma RaysRegenerationAnimalsApoptosisCell SurvivalDNA DamageFemaleGene Expression RegulationGoblet CellsHistonesIntestinal MucosaIntestine, SmallMaleMice, Inbred C57BLMice, KnockoutCbfa2t3 protein, mousegamma-H2AX protein, mouseHistonesNuclear ProteinsRepressor ProteinsTranscription FactorsWnt3A Proteinenteroidintestinal crypt regenerationMTG16radiation enteritistranscriptional corepressors

Identifiers

PMID25573176
PMCPMC4360050
OpenAlexW2163577519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.